NEW YORK (GenomeWeb News) – Coastal Genomics announced that it has licensed from the BC Cancer Agency exclusive rights to a liquid handling automation technology.
The Vancouver, British Columbia-based firm said that the technology would be marketed as the Ranger automated workstation. The system, the company said, will be able to completely automate the process of agarose gel size selection of DNA fragments for between one and 96 samples in a single run.
The BC Cancer Agency's Genome Sciences Centre has been using the technology in house since 2010 and has processed more than 9,000 samples.
"The Ranger automated workstation has greatly improved sample preparation at the BCCA Genome Sciences Centre," Andy Mungall, the centre's library core group leader, said in a statement. "It's cost competitive with other methods and provides high quality output — we have been able to efficiently prepare thousands of samples for several major projects."
Coastal Genomics said that it plans to commercialize the technology this coming summer.
Financial and other terms of the license were not disclosed.